Breaking News Instant updates and real-time market news.

BUD

AB InBev

$95.55

-0.35 (-0.36%)

, BREW

Craft Brew

$13.03

0.56 (4.49%)

08:04
08/23/19
08/23
08:04
08/23/19
08:04

Anheuser-Busch says not making offer to purchase remaining shares of CBA

Anheuser-Busch released the following statement regarding the company's commercial partnership with Craft Brew Alliance: "The long-standing and strong partnership we have with Craft Brew Alliance is extremely valuable to Anheuser-Busch. While we are not making an offer to purchase the remaining shares of CBA, our existing commercial partnership with CBA continues to be a key complement to our industry-leading craft portfolio and we look forward to working together for many years to come." -- Marcelo "Mika" Michaelis, president, Brewers Collective, Anheuser-Busch. Anheuser-Busch and Craft Brew Alliance have a long-lasting and strong commercial relationship that includes distribution and brewing agreements. Anheuser-Busch continues to own a 31.3% stake in CBA.

BUD

AB InBev

$95.55

-0.35 (-0.36%)

BREW

Craft Brew

$13.03

0.56 (4.49%)

  • 01

    Oct

  • 25

    Oct

  • 12

    Nov

BUD AB InBev
$95.55

-0.35 (-0.36%)

07/29/19
07/29/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ericsson (ERIC) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Alexander Duval citing his view that its fundamentals are solid in Networks, Digital Services and Managed Services but the stock has pulled back by about 5% relative to the others in EU Tech since the company's Q2 report on July 17. 2. AB InBev (BUD) upgraded to Buy from Neutral at BofA/Merrill with analyst Fernando Ferreira saying the cycle of downward earnings revisions is coming to an end. 3. Volaris (VLRS) upgraded to Overweight from Equal Weight at Barclays with analyst Pablo Monsivais saying he sees share upside given the company's "simple model" that drives the lowest possible costs. 4. NXP Semiconductors (NXPI) upgraded to Outperform from In Line at Evercore ISI. 5. Gilead (GILD) upgraded to Top Pick from Outperform at RBC Capital with analyst Brian Abrahams saying the stock represents a "compelling opportunity" with limited downside risks as the company's HIV franchise generates a "steady" annual revenue of about $16B per year over the medium term given the "very strong" uptake of its Biktarvy, according to prescription data. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/05/19
JEFF
08/05/19
UPGRADE
JEFF
Hold
AB InBev upgraded to Hold from Underperform at Jefferies
Jefferies analyst Edward Murphy upgraded AB InBev to Hold from Underperform and raised his price target for the shares to 85 euros from 63 euros. The analyst says the company is pivoting to growth while concerns on its leverage are easing.
08/05/19
08/05/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Target (TGT) upgraded to Buy from Hold at Deutsche Bank with analyst Paul Trussell saying Target is "growing profitably" with EBITDA dollars up mid-single-digits in Q1, a pace that can be sustained through supply chain enhancements, market share gains in key categories often with higher margin private brands, and strong returns on remodels and new small format stores. 2. Owens-Illinois (OI) upgraded to Neutral from Sell at Goldman Sachs with analyst Brian Maguire saying the negative catalysts around lower volume and higher taxes have materialized with the stock underperforming since reporting a miss in Q2 earnings last week. 3. AB InBev (BUD) upgraded to Hold from Underperform at Jefferies with analyst saying the company is pivoting to growth while concerns on its leverage are easing. 4. CF Industries (CF) upgraded to Neutral from Underperform at BofA/Merrill with analyst Steve Byrne saying the company's "strong" Q2 results show operational strength and an improving outlook. 5. Builders FirstSource (BLDR) upgraded to In Line from Underperform at Evercore ISI. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/06/19
UBSW
08/06/19
DOWNGRADE
UBSW
Neutral
AB InBev downgraded to Neutral from Buy at UBS
UBS analyst Nik Oliver downgraded AB InBev to Neutral from Buy while raising his price target for the shares to 94 euros from 81 euros. The recent rally in the shares has brought a fair valuation, Oliver tells investors in a research note. The analyst now sees a more balanced risk/reward amid increasing macro headwinds in AB InBev's in large markets. Further, he sees limited near-term acquisition opportunities for the company.
BREW Craft Brew
$13.03

0.56 (4.49%)

01/16/19
MAXM
01/16/19
INITIATION
Target $21
MAXM
Buy
Craft Brew initiated with a Buy at Maxim
Maxim initiated Craft Brew with a Buy rating and a price target of $21.
01/17/19
MAXM
01/17/19
INITIATION
Target $21
MAXM
Buy
Craft Brew initiated with a Buy at Maxim
Maxim analyst Alexander Scharf initiated Craft Brew (BREW) with a Buy rating and a price target of $21. The analyst cites the company's relationship with Anheuser-Busch InBev (BUD) helping position it for growth through "benefits that are typically unavailable to independent craft brewers." Scharf is also positive on Craft Brew gaining share in the soft ber market with its flagship Kona brand.
01/17/19
01/17/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tencent Music (TME) initiated with an Overweight at JPMorgan. 2. Craft Brew (BREW) initiated with a Buy at Maxim while Castle Brands (ROX) was initiated with a Hold. 3. CVS Health (CVS) and LabCorp (LH) were initiated with a Buy at UBS while Walgreens Boots Alliance (WBA) was initiated with a Sell. 4. DTE Energy (DTE) initiated with a Buy at Goldman Sachs while CMS Energy (CMS) was initiated with a Neutral. 5. Zendesk (ZEN) and HubSpot (HUBS) were initiated with an Overweight at Stephens while Adobe (ADBE) was initiated with an Equal Weight. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/03/19
MAXM
05/03/19
INITIATION
Target $21
MAXM
Buy
Craft Brew assumed with a Buy at Maxim
Maxim analyst Anthony Vendetti assumed Craft Brew Alliance (BREW) with a Buy rating and a price target of $21, saying he expects the company's revenue to accelerate in 2019 thanks mostly to the increased marketing for its flagship Kona brand. The analyst also cites Craft Brew's relationship with InBev (BUD) and points to its option to make a qualifying acquisition offer at $24.50 per share by August 23rd.

TODAY'S FREE FLY STORIES

ATUS

Altice USA

$29.51

0.12 (0.41%)

, AMZN

Amazon.com

$1,810.00

-27.49 (-1.50%)

10:01
09/16/19
09/16
10:01
09/16/19
10:01
Hot Stocks
Altice USA to launch Amazon Prime Video on Altice One »

Altice USA (ATUS) and…

ATUS

Altice USA

$29.51

0.12 (0.41%)

AMZN

Amazon.com

$1,810.00

-27.49 (-1.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 27

    Oct

CHD

Church & Dwight

$71.23

-0.79 (-1.10%)

10:01
09/16/19
09/16
10:01
09/16/19
10:01
Conference/Events
Church & Dwight management to meet with Oppenheimer »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 06

    Nov

UNT

Unit Corp.

$4.08

0.76 (22.89%)

10:00
09/16/19
09/16
10:00
09/16/19
10:00
Hot Stocks
Unit Corp. rises 22.3% »

Unit Corp. is up 22.3%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

WLL

Whiting Petroleum

$10.44

2.91 (38.65%)

10:00
09/16/19
09/16
10:00
09/16/19
10:00
Hot Stocks
Whiting Petroleum rises 38.4% »

Whiting Petroleum is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Oct

  • 09

    Oct

SEMG

SemGroup

$16.81

6.53 (63.52%)

10:00
09/16/19
09/16
10:00
09/16/19
10:00
Hot Stocks
SemGroup rises 63.5% »

SemGroup is up 63.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CI

Cigna

$160.67

-0.41 (-0.25%)

09:58
09/16/19
09/16
09:58
09/16/19
09:58
Conference/Events
Cigna management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 31

    Oct

GM

General Motors

$37.76

-1.07 (-2.76%)

09:57
09/16/19
09/16
09:57
09/16/19
09:57
Periodicals
General Motors, UAW restart talks as workers strike, Reuters reports »

General Motors and the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USIO

Usio

$2.23

(0.00%)

09:57
09/16/19
09/16
09:57
09/16/19
09:57
Recommendations
Usio analyst commentary  »

Usio's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

09:55
09/16/19
09/16
09:55
09/16/19
09:55
Hot Stocks
JPMorgan Securities fined $1.1M for failure to disclose misconduct allegations »

FINRA announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 27

    Oct

MTNOY

MTN Group

09:55
09/16/19
09/16
09:55
09/16/19
09:55
Conference/Events
MTN Group management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 19

    Sep

  • 20

    Sep

KR

Kroger

$25.93

-0.32 (-1.22%)

09:55
09/16/19
09/16
09:55
09/16/19
09:55
Options
Kroger put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MUR

Murphy Oil

, DO

Diamond Offshore

09:55
09/16/19
09/16
09:55
09/16/19
09:55
Options
Early notable gainers among liquid option names on September 16th »

Notable gainers among…

MUR

Murphy Oil

DO

Diamond Offshore

RIG

Transocean

MRO

Marathon Oil

HAL

Halliburton

$21.87

1.605 (7.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 13

    Nov

ATRA

Atara Biotherapeutics

$14.61

-0.55 (-3.63%)

09:51
09/16/19
09/16
09:51
09/16/19
09:51
Downgrade
Atara Biotherapeutics rating change  »

Jefferies sees no…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

WBS

Webster Financial

$48.58

-0.71 (-1.44%)

09:50
09/16/19
09/16
09:50
09/16/19
09:50
Conference/Events
Webster Financial management to meet with Wedbush »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 13

    Nov

VST

Vistra Energy

09:48
09/16/19
09/16
09:48
09/16/19
09:48
Conference/Events
Vistra Energy management to meet with Morgan Stanley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 02

    Oct

EYE

National Vision

$30.20

-0.46 (-1.50%)

09:48
09/16/19
09/16
09:48
09/16/19
09:48
Hot Stocks
National Vision down 1% in early trading »

National Vision shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZYNE

Zynerba

$11.91

-0.27 (-2.22%)

09:47
09/16/19
09/16
09:47
09/16/19
09:47
Initiation
Zynerba initiated  »

Zynerba assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

VNE

Veoneer

$17.68

-0.355 (-1.97%)

09:46
09/16/19
09/16
09:46
09/16/19
09:46
Conference/Events
Veoneer management to meet with Buckingham »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 23

    Oct

ABR

Arbor Realty

$12.88

0.04 (0.31%)

09:45
09/16/19
09/16
09:45
09/16/19
09:45
Conference/Events
Arbor Realty management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 19

    Sep

  • 20

    Sep

LHX

L3Harris Technologies

$211.04

3.42 (1.65%)

09:45
09/16/19
09/16
09:45
09/16/19
09:45
Recommendations
L3Harris Technologies analyst commentary  »

L3Harris Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
09/16/19
09/16
09:45
09/16/19
09:45
General news
Fed funds futures are rallying as risk aversion takes hold »

Fed funds futures are…

UPS

UPS

$122.66

(0.00%)

09:43
09/16/19
09/16
09:43
09/16/19
09:43
Conference/Events
UPS management to meet with Loop Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 19

    Sep

ARWR

Arrowhead

$29.91

(0.00%)

09:42
09/16/19
09/16
09:42
09/16/19
09:42
Recommendations
Arrowhead analyst commentary  »

Arrowhead to initiate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALDR

Alder Biopharmaceuticals

$10.05

(0.00%)

09:42
09/16/19
09/16
09:42
09/16/19
09:42
Recommendations
Alder Biopharmaceuticals analyst commentary  »

Piper says Lundbeck deal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Feb

BLK

BlackRock

$443.15

(0.00%)

09:41
09/16/19
09/16
09:41
09/16/19
09:41
Recommendations
BlackRock analyst commentary  »

BlackRock recent selloff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.